Anti-infective Drug Use in Relation to the Risk of Agranulocytosis and Aplastic Anemia
- 1 May 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 149 (5) , 1036-1040
Abstract
Research from JAMA Internal Medicine — Anti-infective Drug Use in Relation to the Risk of Agranulocytosis and Aplastic Anemia — A Report From the International Agranulocytosis and Aplastic Anemia StudyKeywords
This publication has 16 references indexed in Scilit:
- Hematological side effects of co-trimoxazoleInfection, 1987
- Risks of Agranulocytosis and Aplastic Anemia. A First Report of their Relation to Drug Use with Special Reference to AnalgesicsJournal of Urology, 1987
- CSM Update: Anti-infective drugs: Adverse effects reported on yellow cardsBMJ, 1986
- The design of a study of the drug etiology of agranulocytosis and aplastic anemiaEuropean Journal of Clinical Pharmacology, 1983
- Drug‐Induced Neutropenia—A Survey for Stockholm 1973–1978Acta Medica Scandinavica, 1982
- ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIESAmerican Journal of Epidemiology, 1976
- Aplastic anemia in Israel: evaluation of the etiological role of chloramphenicol on a community-wide basisThe American Journal of the Medical Sciences, 1975
- PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1American Journal of Epidemiology, 1974
- Drug-induced Blood Dyscrasias in SwedenBMJ, 1973
- A FATAL CASE OF APLASTIC ANEMIA FOLLOWING CHLORAMPHENICOL (CHLOROMYCETIN) THERAPYAnnals of Internal Medicine, 1950